Paediatric Cancer Brain LGG2: Cooperative multicenter study for children and adolescents with Low Grade Glioma GD2: A Phase I/II dose schdule finding study of CH14.18/CHO continuous infusion combined wugt subcutaneous aldesleukin (IL-2) in patients with primary refractory or relapsed neuroblastoma. LGG2@trials.bham.ac.uk GD2@trials.bham.ac.uk Germ Cell SIOP CNS GCT II: Prospective trial for the diagnosis and treatment of children, adolescents and young adults with intracranial germ cell tumours can-crctu-cctt@adf.bham.ac.uk Embryonic Tumour HRNBL: High risk neuroblastoma study 1 of SIOP- Europe (SIOPEN) hrnbl@trials.bham.ac.uk Haematology Malignancies Interfant 06: International collaborative treatment protocol for infants under one year with acute lymphoblastic or biphenotypic leukaemia (LK 2006 10) EuroNet PHL C-1: First International Inter-Group Study for Classical Hodgkin s Lymphoma in Children and Adolescents UKALL 2011: United Kingdom National Randomised Trial for Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoma 2011 EuroNet PHL LP1: First international Inter-Group Study for nodular lymphocyte-predominant Hodgkin s Lymphoma in Children and Adolescents Inter-B-NHL 2010: Intergroup trial for children or adolescents with B-Cell NHL or B-AL: evaluation of rituximab efficacy and safety in high risk patients interfant06@trials.bham.ac.uk euronetphl@trials.bham.ac.uk ukall2011@trials.bham.ac.uk can-crctu-cctt@adf.bham.ac.uk interbnhl@trials.bham.ac.uk
Liver SIOPEL 6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate in reducing ototoxicity in patients receiving cisplatin chemotherapy for standard risk hepatoblastoma siopel6@trials.bham.ac.uk Renal SIOP WILMS: SIOP nephroblastoma (wilms tumour) clinical trial and study siopwilms@trials.bham.ac.uk Sarcoma RMS 2005: A protocol for non metastatic rhabdomyosarcoma (STS 2006 04) EE99: EUROpean Ewing tumour working initiative of national groups. Ewing tumour studies 1999 VIT0910: International randomised phase II trial of the combination of Vincristine and Irinotecan with or without Temozolomide (VI or VIT) in patients with refractory or relapsed Rhabdomyosarcoma rms2005@trials.bham.ac.uk EE99@trials.bham.ac.uk VIT0910@trials.bham.ac.uk Adult Cancer Bladder HYMN: A randomised controlled Phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guérin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guérin therapy HYMN@trials.bham.ac.uk TUXEDO: Phase I/II feasibility study of cetuximab with cisplatin or 5FU and Mitomycin C with concurrent radiotherapy in muscle invasive bladder cancer Brain can-crctu-teama@adf.bham.ac.uk BPA: A Cancer Research UK pharmacokenetic study of p- boronophenylalanine (BPA) in patients with high glioma of optimise uptake parameters for clinical trials of boron neutron capture therapy can-crctu-edd@adf.bham.ac.uk Breast NEO-EXCEL: Neoadjuvant trial of pre-operative exemestane or neoexcel@trials.bham.ac.uk letrozole +/-celecoxib in the treatment of ER positive postmenopausal early breast cancer
Haematology Malignancies RICAZA: Phase II study of the tolerability of adjunctive Azacitidine in patients undergoing reduced intensity allogeneic stem cell transplantation for Acute Myeloid Leukaemia TRICE: Phase I/II study of the adjunctive use of Nilotinib in patients undergoing reduced intensity allogeneic transplantation for Imatinib resistant or intolerant Chronic Myeloid Leukaemia val/aza: Phase II study of the tolerability and efficacy of the histone deacetylase inhibitor sodium valproate administered in conjunction with 5-azacitidine, ATRA (all trans retinoic acid) and theophylline in patients with Acute Myeloid Leukaemia and high risk MDS ricaza@trials.bham.ac.uk trice@trials.bham.ac.uk valaza@trials.bham.ac.uk PICLLe: Phase I/II clinical trial to assess the efficacy and safety piclle@trials.bham.ac.uk of olaparib, a PARP-inhibitor, in relapsed and refractory chronic lymphocytic leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T- prolymphocytic leukaemia and mantle cell lymphoma LenaRIC: Phase II study of the adjunctive use of lenalidomide lenaric@trials.bham.ac.uk in patients undergoing reduced intensity conditioning allogeneic transplantation for multiple myeloma MAJIC: A phase II study of Ruxolitinib (INCB424) in patients with High Risk Polycythaemia Vera or Essential Thrombocythaemia resistant to or intolerant of standard therapy BaP Pilot: Single Arm Phase II trial assessing the efficacy, compliance and safety of Bezafibrate and medroxyprogesterone acetate (BaP) as non-toxic therapy against myeloid and lymphoid cancers. DeIron: A phase II study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes HA-1: A phase I clinical trial of the vaccination of healthy human volunteers against the minor histocompatibility antigen (mhag) HA-1 using a DNA and MVA prime/boost regimen RAvVA: A Randomised Phase II Trial of 5-Azacitidine versus Vorinostat in Combination with 5-Azacitidine in patients with Relapsed Acute Myeloid Leukaemia for Salvage Chemotherapy MAJIC@trials.bham.ac.uk De-iron@trials.bham.ac.uk HA1@trials.bham.ac.uk can-crctuhaematology@adf.bham.ac.uk can-crctuhaematology@adf.bham.ac.uk Head and Neck ArChIMEDEs Op: Accelerated Hypofractionation, Chemotherapy, Intensity Modulation and Evaluation of Dose Escalation in Oropharyngeal Cancer can-crctu-teamb@adf.bham.ac.uk
Hepatocellular Carcinoma BILCAP: A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following surgery for biliary tract cancer TACE-2: A randomised placebo-controlled, double-blinded, phase III trial of sorafenib in combination with transarterial chemoembolisation in hepatocellular cancer Homing of DCs: A clinical study of the homing of mature autologous dendritic cells in vivo in patients with hepatocellular carcinoma or liver metastases. bilcap@trials.bham.ac.uk TACE2@trials.bham.ac.uk can-crctu-edd@adf.bham.ac.uk Lung STOMP: A randomised phase II study of AZD2281 maintenance treatment in patients with chemosensitive small cell lung cancer STOMP@trials.bham.ac.uk 3D-i: A dose-finding study of combination chemotherapy with can-crctu-edd@adf.bham.ac.uk cisplatin, pemetrexed and docetaxel in the first line treatment of advanced non-squamous non small cell lung cancer. NOURISH P2: Improving the management of cachexia in Nourish@trials.bham.ac.uk patients with advanced lung cancer: Does the introduction of beta-hydroxy-beta-methylbutyrate supplementation improve nutritional status and quality of life? Mixed Primary NOURISH Pilot 1: A pilot study to determine changes in lean body mass in people with cancer. Nourish@trials.bham.ac.uk Prostate Trapeze: A randomised phase II/III study of docetaxel plus prednisolone vs docetaxel plus prednisolone plus zoledronic acid vs docetaxel plus prednisolone plus strontium-89 vs docetaxel plus prednisolone plus zoledronic acid plus strontium-89 in hormone refractory prostate cancer metastatic to bone trapeze@bham.ac.uk AdUP: A phase 1 clinical trial of a replication defective Ad5 vector expressing nitroreductase and GMCSF (AdNRGM) given via brachytherapy, followed by CB1954, in patients with locally relapsed prostate cancer Alpharadin: Alpharadin and docetaxel randomised phase II trial to assess the feasibility and safety of the combination of docetaxel plus Ra-223 (Alpharadin) in the first line chemotherapy treatment of men with bony metastatic castrate resistant prostate cancer can-crctu-edd@adf.bham.ac.uk can-crctu-teama@adf.bham.ac.uk
Renal PAZ02: A study of pazopanib efficacy and safety in patients with advanced clear-cell renal cell carcinoma and Performance Status 2 (ECOG) Sarcoma can-crctu-teama@adf.bham.ac.uk Vortex: Randomised trial of dose and volume of post-operative radiotherapy given to adult patients with extremity soft tissue sarcoma Axi-STS: A clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas SCART: Phase I/II study of oral MEK inhibitor Selumetinib (AZD6244 Hyd-Sulphate) in Combination with Highly Active Anti-Retroviral Therapy (HAART) in AIDS-associated Kaposi s sarcoma (KS). vortex@trials.bham.ac.uk Axi-STS@trials.bham.ac.uk scart@trials.bham.ac.uk Skin UKMCC-01: A phase II study of pazopanib in metastatic merkel can-crctu-teamb@adf.bham.ac.uk cell carcinoma SPOT: Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments (SPOT): a feasibility study Ovary can-crctu-teamb@adf.bham.ac.uk DESKTOP III: A randomized multicenter study to compare the efficacy of additional tumour debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer DESKTOPIII@trials.bham.ac.uk
Adult Non-Cancer Liver LEAN: A 48-week phase II, randomised, double blinded placebo controlled, parallel-group, multi centre trial on Liraglutide s safety, efficacy and action on liver histology and mechanism in overweight patients with non-alcoholic steatohepatitis, with or without type II diabetes REALISTIC: A multicentre, phase II, open label, randomised controlled trial of repeated autologous infusions of g-csf mobilised CD133+ bone marrow stem cells in patients with cirrhosis ITX5061: Phase I study of Hepatitis C Virus (HCV) entry inhibitor (ITX5061) in liver transplant recipients with HCV infection lean@trials.bham.ac.uk Realistic@trials.bham.ac.uk ITX5061@trials.bham.ac.uk IMMUNOTACE: A phase II randomised clinical trial of Immunotace@trials.bham.ac.uk conditioning cyclophosphamide and chemoembolisation with or without vaccination with Dendritic Cells pulsed with HepG2 lysate in vivo in patients with Hepatocellular Carcinoma